Postoperative complication of stent. Drugs, medicaments and biological substances causing adverse effects in therapeutic use
Conditions
Interventions
Intervention 1: Intervention group: In the total tubeless PCNL group, at the end of the procedure, no stent will be implanted for the patient and the patient will be completely tubeless. Intervention
Sponsors
Urology Research Center, Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 20 years Consent of patients to participate in the study
Exclusion criteria
Exclusion criteria: Metabolic disease known to predispose to stones Transplanted kidney stones Renal failure requiring chronic dialysis before surgery Anatomical problems (ureteral stricture, duplicate ureter, single kidney,...) Bleeding during surgery Occurrence of any surgical complications during the operation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative fever. Timepoint: After the operation until the time of discharge. Method of measurement: Examination using a thermometer.;Postoperative infection. Timepoint: 48 hours after surgery. Method of measurement: Lab test and urine culture.;Postoperative hemoglobin. Timepoint: 24 hours after surgery. Method of measurement: Complete blood count (CBC) test.;Postoperative creatinine. Timepoint: 24 hours after surgery. Method of measurement: Blood test by kinetic Jaffe's and enzymatic method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahab Aali
Rasht University of Medical Sciences
Outcome results
None listed